Aureka Biotechnologies and BD Biosciences Commence Project to Accelerate Reagent Antibody Development
Aureka Biotechnologies (“Aureka Bio”), a premier biotech startup in AI-based protein engineering, is thrilled to announce a project with BD (Becton, Dickinson and Company), a leading global medical technology company to harness Aureka Bio’s generative AI-empowered antibody discovery and engineering platform to develop high-performance research reagents for scientific research.
